Anadys raises $25 million

Anadys Pharmaceuticals Inc. (NASDAQ:ANDS) raised $25 million through the sale of 13.9 million shares at $1.80 in a follow-on underwritten by Lazard. The company proposed the offering late Thursday, wh...